Waggoner S - Search Results

1

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol.

Creasman WT, Ali S, Mutch DG, Zaino RJ, Powell MA, Mannel RS, Backes FJ, DiSilvestro PA, Argenta PA, Pearl ML, Lele SB, Guntupalli SR, Waggoner S, Spirtos N, Boggess JF, Edwards RP, Filiaci VL, Miller DS. Creasman WT, et al. Among authors: waggoner s. Gynecol Oncol. 2017 Jun;145(3):519-525. doi: 10.1016/j.ygyno.2017.03.017. Epub 2017 Apr 6. Gynecol Oncol. 2017. PMID: 28392124 Free PMC article.

2

Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Rose PG, Blessing JA, Van Le L, Waggoner S. Rose PG, et al. Among authors: waggoner s. Gynecol Oncol. 1998 Aug;70(2):263-6. doi: 10.1006/gyno.1998.5097. Gynecol Oncol. 1998. PMID: 9740702 Clinical Trial.

3

The significance of adnexal involvement in endometrial carcinoma.

Connell PP, Rotmensch J, Waggoner S, Mundt AJ. Connell PP, et al. Among authors: waggoner s. Gynecol Oncol. 1999 Jul;74(1):74-9. doi: 10.1006/gyno.1999.5415. Gynecol Oncol. 1999. PMID: 10385554 Review.

4

Phase II evaluation of 24-h continuous infusion topotecan in recurrent, potentially platinum-sensitive ovarian cancer: A Gynecologic Oncology Group study.

Markman M, Blessing JA, Alvarez RD, Hanjani P, Waggoner S, Hall K. Markman M, et al. Among authors: waggoner s. Gynecol Oncol. 2000 Apr;77(1):112-5. doi: 10.1006/gyno.2000.5755. Gynecol Oncol. 2000. PMID: 10739699 Clinical Trial.

5

Age as a prognostic factor for recurrence in patients with endometrial carcinoma.

Mundt AJ, Waggoner S, Yamada D, Rotmensch J, Connell PP. Mundt AJ, et al. Among authors: waggoner s. Gynecol Oncol. 2000 Oct;79(1):79-85. doi: 10.1006/gyno.2000.5917. Gynecol Oncol. 2000. PMID: 11006036

6

Outcome of endometrial carcinoma patients with involvement of the uterine serosa.

Ashman JB, Connell PP, Yamada D, Rotmensch J, Waggoner SE, Mundt AJ. Ashman JB, et al. Among authors: waggoner se. Gynecol Oncol. 2001 Aug;82(2):338-43. doi: 10.1006/gyno.2001.6189. Gynecol Oncol. 2001. PMID: 11531290

7

Outcome and management of pathological stage I endometrial carcinoma patients with involvement of the lower uterine segment.

Phelan C, Montag AG, Rotmensch J, Waggoner SE, Yamada SD, Mundt AJ. Phelan C, et al. Among authors: waggoner se. Gynecol Oncol. 2001 Dec;83(3):513-7. doi: 10.1006/gyno.2001.6407. Gynecol Oncol. 2001. PMID: 11733964

8

A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: a gynecologic oncology group study.

Miller DS, Blessing JA, Lentz SS, Waggoner SE. Miller DS, et al. Among authors: waggoner se. Gynecol Oncol. 2002 Dec;87(3):247-51. doi: 10.1006/gyno.2002.6804. Gynecol Oncol. 2002. PMID: 12468321 Clinical Trial.

9

Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Fracasso PM, Blessing JA, Wolf J, Rocereto TF, Berek JS, Waggoner S. Fracasso PM, et al. Among authors: waggoner s. Gynecol Oncol. 2003 Jul;90(1):177-80. doi: 10.1016/s0090-8258(03)00253-1. Gynecol Oncol. 2003. PMID: 12821360 Clinical Trial.

10

Phase II evaluation of 9-aminocamptothecin (9-AC, NSC #603071) in platinum-resistant ovarian and primary peritoneal carcinoma: a Gynecologic Oncology Group Study.

Miller DS, Blessing JA, Waggoner S, Schilder J, Sorosky J, Bloss J, Schilder R. Miller DS, et al. Among authors: waggoner s. Gynecol Oncol. 2005 Jan;96(1):67-71. doi: 10.1016/j.ygyno.2004.09.015. Gynecol Oncol. 2005. PMID: 15589582 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters